Progyny sees FY25 adjusted EPS $1.52-$1.62, consensus $1.66

Sees FY25 revenue $1.18B-$1.23B, consensus $1.16B. Sees Fy25 adjusted EBITDA $188M-$201M. “We have continued to see improvement with first quarter member engagement on a seasonally adjusted basis as compared to historical patterns. However, due to the unexpected variability we experienced in 2024, the guidance ranges we’re issuing today reflect the possibility that we’ll see further variability in engagement in 2025,” said Anevski.